Cargando…
Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687366/ https://www.ncbi.nlm.nih.gov/pubmed/36438803 http://dx.doi.org/10.3389/fphar.2022.1072353 |
| _version_ | 1784835987333971968 |
|---|---|
| author | Blas-García, Ana Cubero, Francisco Javier |
| author_facet | Blas-García, Ana Cubero, Francisco Javier |
| author_sort | Blas-García, Ana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9687366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96873662022-11-25 Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets Blas-García, Ana Cubero, Francisco Javier Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9687366/ /pubmed/36438803 http://dx.doi.org/10.3389/fphar.2022.1072353 Text en Copyright © 2022 Blas-García and Cubero. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Blas-García, Ana Cubero, Francisco Javier Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title | Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title_full | Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title_fullStr | Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title_full_unstemmed | Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title_short | Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets |
| title_sort | editorial: advances in non-alcoholic fatty liver disease therapeutics: pathogenic mechanisms and targets |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687366/ https://www.ncbi.nlm.nih.gov/pubmed/36438803 http://dx.doi.org/10.3389/fphar.2022.1072353 |
| work_keys_str_mv | AT blasgarciaana editorialadvancesinnonalcoholicfattyliverdiseasetherapeuticspathogenicmechanismsandtargets AT cuberofranciscojavier editorialadvancesinnonalcoholicfattyliverdiseasetherapeuticspathogenicmechanismsandtargets |